Cell Reagents

PreceDo provides a robust portfolio of patient‑derived primary cell and organoid culture platforms, developed and patented in‑house to support high‑quality discovery across tumor, inflammatory, and normal tissue systems such as liver, lung, and skin. Our models deliver reliable biological relevance for mechanism studies, therapeutic evaluation, and translational research.

60 +

Patents

19 +

Diseases

70 +

Products

Reprogramming Cells, Empowering Medicine

GO

Sample Request

Registration of Human Sample Requirements

Action
Remove
Submit

Sample Request

Registration of Human Sample Requirements

Action
Remove
Submit